Imperial Tobacco Group PLC (OTCMKTS:IMBBY) Sees Significant Drop in Short Interest

Imperial Tobacco Group PLC (OTCMKTS:IMBBY) saw a significant decrease in short interest in June. As of June 30th, there was short interest totaling 44,255 shares, a decrease of 81.9% from the June 15th total of 244,875 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 342,422 shares, the short-interest ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, UBS Group cut Imperial Tobacco Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 15th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Imperial Tobacco Group Stock Performance

IMBBY stock traded down $0.21 during mid-day trading on Friday, hitting $36.54. The company had a trading volume of 95,873 shares, compared to its average volume of 153,718. Imperial Tobacco Group has a 12 month low of $35.90 and a 12 month high of $45.60. The stock’s fifty day moving average price is $37.42 and its two-hundred day moving average price is $40.18.

Imperial Tobacco Group Company Profile

Imperial Tobacco Group, historically established in the United Kingdom in 1901 and now operating under the Imperial Brands name, is a multinational tobacco and nicotine company headquartered in Bristol, England. The company’s core business is the manufacture, marketing and sale of tobacco products and alternative nicotine offerings to adult consumers. It supplies products through a combination of owned channels and third-party distributors and focuses on managing an international portfolio of consumer tobacco and nicotine brands.

Product categories include manufactured cigarettes, cigars and fine-cut tobacco for roll-your-own use, together with a growing range of next-generation nicotine products such as vaping devices, heated tobacco and non-combustible nicotine formats that reflect a strategic shift toward reduced-risk alternatives.